Somatic Mutations of PTEN in Glioblastoma Multiforme

Overview

Journal Cancer Res

Specialty Oncology

Date 1997 Oct 23

PMID 9331071

Citations 150

Authors

S I Wang

J Puc

J Li

J N Bruce

P Cairns

D Sidransky

R Parsons

Affiliations

Soon will be listed here.

Abstract

Alterations of the PTEN gene occur in glioblastoma multiforme. To determine the frequency of PTEN alteration, 34 consecutive glioblastomas were studied in detail. Sequencing each of the nine exons amplified from tumor DNA revealed 11 mutations. Analysis of polymorphic markers within and surrounding the PTEN gene identified an additional four homozygous deletion mutations. Loss of heterozygosity (LOH) was observed in 25 of 34 (74%) cases. All mutations occurred in the presence of LOH. PTEN was mutated in 44% (15 of 34) of all glioblastomas studied and 60% (15 of 25) of tumors with LOH on 10q. Thus, PTEN appears to be the major target of inactivation on chromosome 10q in glioblastoma multiforme.

Citing Articles

Rodent models of tumours of the central nervous system.

Brandner S Mol Oncol. 2024; 18(12):2842-2870.

PMID: 39324445 PMC: 11619804. DOI: 10.1002/1878-0261.13729.

Haploinsufficiency of Adenomatous Polyposis Coli Coupled with Kirsten Rat Sarcoma Viral Oncogene Homologue Activation and P53 Loss Provokes High-Grade Glioblastoma Formation in Mice.

Fang K, Su C, Layos J, Lau N, Cheng K Cancers (Basel). 2024; 16(5).

PMID: 38473403 PMC: 10930734. DOI: 10.3390/cancers16051046.

Detection of driver mutations and genomic signatures in endometrial cancers using artificial intelligence algorithms.

Stan A, Bosart K, Kaur M, Vo M, Escorcia W, Yoder R PLoS One. 2024; 19(2):e0299114.

PMID: 38408048 PMC: 10896512. DOI: 10.1371/journal.pone.0299114.

The myocardium utilizes a platelet-derived growth factor receptor alpha (Pdgfra)-phosphoinositide 3-kinase (PI3K) signaling cascade to steer toward the midline during zebrafish heart tube formation.

Shrestha R, McCann T, Saravanan H, Lieberth J, Koirala P, Bloomekatz J Elife. 2023; 12.

PMID: 37921445 PMC: 10651176. DOI: 10.7554/eLife.85930.

, , microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics.

Travis G, McGowan E, Simpson A, Marsh D, Nassif N Cancers (Basel). 2023; 15(20).

PMID: 37894321 PMC: 10605164. DOI: 10.3390/cancers15204954.